GILD

Gilead Sciences, Inc. News Headlines

$89.84
*  
0.70
0.77%
Get GILD Alerts
*Delayed - data as of Jul. 25, 2014  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Cramer's Mad Money - Facebook's Triumph (7/25/13)
7/26/2013 5:59:00 AM - Seeking Alpha

Gilead Sciences, Inc. (GILD) Management Discusses Q2 2013 Results (Webcast)
7/25/2013 4:31:00 PM - Seeking Alpha

4 Months Post-IPO, Enanta Pharmaceuticals Carries Compelling Valuation Next To Hepatitis Peers
7/24/2013 5:34:00 PM - Seeking Alpha

Today's Market: Tech Was Disappointing, But Biotech Offers Hope This Week
7/22/2013 8:40:00 AM - Seeking Alpha

Innovations In HIV: Johnson & Johnson, Glaxo Vs. Gilead
7/21/2013 5:45:00 PM - Seeking Alpha

iShares Nasdaq Biotechnology ETF In Play With M&A Activity And Upcoming Earnings Date
7/21/2013 12:19:00 PM - Seeking Alpha

Cramer's Mad Money - Throw Out The Hedge Fund Playbook (7/16/13)
7/17/2013 6:46:00 AM - Seeking Alpha

2 Biotechs With Recent Intensive Insider Selling
7/10/2013 3:27:00 PM - Seeking Alpha

Immunogen: A Game Changing Stock With Tremendous Upside Potential
7/5/2013 1:57:00 PM - Seeking Alpha

Cramer's Mad Money - Noodles & Company Is The Son Of Chipotle (7/1/13)
7/2/2013 6:00:00 AM - Seeking Alpha

3 Sources Of Revenue For Incyte
6/26/2013 11:58:00 AM - Seeking Alpha

ViiV Healthcare Partnership Anticipates New HIV Treatment Approval
6/21/2013 7:56:00 PM - Seeking Alpha

The State Of The Hepatitis C Pill Race: Gilead Vs. AbbVie
6/20/2013 3:59:00 PM - Seeking Alpha

Amgen In Focus
6/19/2013 9:13:00 AM - Seeking Alpha

An Interview With Elemer Piros: A Strong Year For Biotechs, Looking From The Halfway Point
6/18/2013 11:34:00 AM - Seeking Alpha

The Biggest Companies That Don't Pay Dividends - But May Be About To
6/14/2013 2:33:00 PM - Seeking Alpha

Consider Biotech Gilead Sciences Because Of Atripla, Sofosbuvir And Great R&D
6/14/2013 7:41:00 AM - Seeking Alpha

China Biologic: A Star Small-Cap Pick From China
6/13/2013 11:44:00 AM - Seeking Alpha

Warning: This Might Be The Most Overvalued Sector In The Market
6/12/2013 8:47:00 PM - Seeking Alpha

2 Services Sector Companies And 1 Biotech With Recent Intensive Insider Selling
6/12/2013 10:31:00 AM - Seeking Alpha

Infinity Pharma's Safety Concerns: For Patient Investors, A Buying Opportunity
6/10/2013 12:51:00 PM - Seeking Alpha

Infinity Pharmaceuticals And IPI-145: ASCO 2013 Highlights
6/10/2013 9:54:00 AM - Seeking Alpha

Gilead Sciences: Buy Stance For Investors
6/7/2013 11:58:00 AM - Seeking Alpha

The Race For Oral HCV?
5/31/2013 11:27:00 AM - Seeking Alpha

Gilead In The Fight Against Cancer
5/31/2013 5:22:00 AM - Seeking Alpha